Articles dans des revues avec comité de lecture (400)
57.
Ifie, E., Russell, M. M., Dhayal, S., Leete, P., Sebastiani, G., Nigi, L., Dotta, F., Marjomäki, V., Eizirik, D. L., Morgan, N. N., & Richardson, S. S. (2018). Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells. Diabetologia, 61(11), 2344-2355. doi:10.1007/s00125-018-4704-158.
Dos Santos, R. S., Marroqui, L., Velayos, T., Olazagoitia-Garmendia, A., Jauregi-Miguel, A., Castellanos-Rubio, A., Eizirik, D. L., Castaňo, L., & Santin, I. (2018). DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway. Diabetologia. doi:10.1007/s00125-018-4782-059.
Cereijo, R., Gavaldà-Navarro, A., Cairó, M., Quesada-López, T., Villarroya, J., Morón-Ros, S., Sánchez-Infantes, D., Peyrou, M., Iglesias, R., Mampel, T., Turatsinze, J. V., Eizirik, D. L., Giralt, M., & Villarroya, F. (2018). CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation. Cell Metabolism, 28(5), 750-763.e6. doi:10.1016/j.cmet.2018.07.01560.
Colli, M. L., Hill, J. L. E., Marroquí, L., Chaffey, J., Dos Santos, R. S., Leete, P., Coomans De Brachene, A., Paula, F. M. M., Op De Beeck, A., Castela, A., Marselli, L., Krogvold, L., Dahl-Jorgensen, K., Marchetti, P., Morgan, N. G., Richardson, S. J., & Eizirik, D. L. (2018). PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction. EBioMedicine, 36, 367-375. doi:10.1016/j.ebiom.2018.09.04061.
Zhong, L., Tran, T. A., Baguley, T. T., Lee, S. J., Henke, A., To, A., Li, S., Yu, S., Grieco, F. A., Roland, J., Schultz, P., Eizirik, D. L., Rogers, N., Chartterjee, A. A., Tremblay, M. M., & Shen, W. (2018). A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction. British Journal of Pharmacology, 175(17), 3470-3485. doi:10.1111/bph.1438862.
Bugliani, M., Syed, F., Paula, F. M. M., Omar, B. A., Suleiman, M., Mossuto, S., Grano, F., Cardarelli, F., Boggi, U., Vistoli, F., Filipponi, F., De Simone, P., Marselli, L., De Tata, V., Ahren, B., Eizirik, D. L., & Marchetti, P. (2018). DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes. Molecular and cellular endocrinology, 473, 186-193. doi:10.1016/j.mce.2018.01.01963.
Demine, S., Balhuizen, A., Debaille, V., Joosten, L., Fereau, M., Chilla, S. N. M., Millard, I., Scharfmann, R., Egrise, D., Goldman, S., Marchetti, P., Gotthardt, M., Laurent, S., Burtea, C., & Eizirik, D. L. (2018). Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa. Molecules, 23(9). doi:10.3390/molecules2309210064.
Nardelli, T. R., Vanzela, E. C., Benedicto, K. K., Brozzi, F., Fujita, A., Cardozo, A. K., Eizirik, D. L., Boschero, A. C., & Ortis, F. (2018). Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition. Journal of molecular endocrinology, 61(1), 25-36. doi:10.1530/JME-16-025766.
Coomans De Brachene, A., Dos Santos, R. S., Marroqui, L., Colli, M. L., Marselli, L., Mirmira, R. R., Marchetti, P., & Eizirik, D. L. (2018). IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia. doi:10.1007/s00125-017-4536-467.
He, X., Lai, Q., Chen, C., Li, N., Sun, F., Huang, W., Zhang, S., Yu, Q., Yang, P., Xiong, F., Chen, Z., Gong, Q., Ren, B., Weng, J., Eizirik, D. L., Zhou, Z., & Wang, C.-Y. (2018). Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. Diabetologia. doi:10.1007/s00125-017-4523-9